Use App
Trending
News
Earnings
All
DIA
0.83%
SPY
1.02%
QQQ
1.73%
Trending
NFLX
0.51%
USO
3.94%
GLXY
4.74%
PSKY
4.11%
DJT
3.72%
SHIB
0.34%
SPY
1.02%
SPCX
3.93%
SQQQ
5.20%
QXO
2.89%
NFLX
0.51%
USO
3.94%
GLXY
4.74%
PSKY
4.11%
DJT
3.72%
SHIB
0.34%
SPY
1.02%
SPCX
3.93%
SQQQ
5.20%
QXO
2.89%
home
Symbol
LLYX
news
LLYX
Defiance Daily Target 2X Long LLY ETF
$25.20
$1.26
(4.80%)
Today
·
Closed $24.99
$0.21
(0.84%)
Overnight
Updated:
08:32 PM EDT
1
2
5
1
2
5
Vol
341,169.00
52W High
$28.44
52W Low
$9.60
Full Chart
Fundamentals
Volume
-
52W High
$28.44
52W Low
$9.60
Avg. Volume
558,150.49
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
Full Article
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
Full Article
<
...
1
>
Advertisement
|
Remove ads.
Latest LLYX News
View
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Stocktwits
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
Stocktwits
Loading...
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile